Review



cd34 + human cord blood stem cells  (Lonza)


Bioz Verified Symbol Lonza is a verified supplier
Bioz Manufacturer Symbol Lonza manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Lonza cd34 + human cord blood stem cells
    Cd34 + Human Cord Blood Stem Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/4d+nucleofector/pm40645177-875-9-21
    Average 90 stars, based on 1 article reviews
    cd34 + human cord blood stem cells - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Irradiation:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Injection:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Derivative Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Flow Cytometry:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Expressing:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Blocking Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Recombinant:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    CRISPR:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Staining:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Lysis:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Western Blot:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Saline:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Bicinchoninic Acid Protein Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Software:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Single Cell Gel Electrophoresis:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Cell Culture:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Bioassay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Membrane:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Ex Vivo:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Activation Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    In Vitro:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    MANN-WHITNEY:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Generated:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Imaging:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Control:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Inhibition:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    In Vivo:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Purification:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Transplantation Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Negative Control:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    cDNA Synthesis:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    SYBR Green Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Cell Isolation:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Virus:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Gene Expression:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    shRNA:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Screening Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Infection:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Two Tailed Test:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Real-time Polymerase Chain Reaction:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Over Expression:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Transfection:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Selection:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Isolation:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Functional Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Variant Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Mutagenesis:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Methylation:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Immunoprecipitation:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Plasmid Preparation:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Affinity Purification:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Immunohistochemistry:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Labeling:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Megacult Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Protease Inhibitor:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Modification:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Protein Purification:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Viability Assay:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.

    Sequencing:

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
    Article Snippet: Human cord blood CD34 + haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A p38 MAPK-ROS axis fuels proliferation stress and DNA damage during CRISPR-Cas9 gene editing in hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34 + Stem/Progenitor cells , Lonza , Cat#2C-101.

    Article Title: Human CD34 + -derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
    Article Snippet: Human cord blood CD34 + hematopoietic stem and progenitor cells (HSCs) , Lonza , Cat#:2C-101.

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells
    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Article Title: Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.
    Article Snippet: Human cord blood CD34+ haematopoietic stem cells (HSC) (Lonza) were thawed, counted and resuspended according to manufacturer’s protocols.

    Article Title: A cloaked human stem-cell-derived neural graft capable of functional integration and immune evasion in rodent models.
    Article Snippet: Cells were cultured for 3 days in one well of a 24-well tissue culture plate (BD Falcon) at 37 C in a 5% CO2 incubator.

    Article Title: Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo.
    Article Snippet: Within two hours of irradiation, mice were injected with 5x10 4 - 1x10 5 CD34 + human cord blood stem cells (Lonza, Basel, Switzerland) by intra-facial injection in 30ml PBS.

    Article Title: Methylation of dual-specificity phosphatase 4 controls cell differentiation
    Article Snippet: Human cord blood CD34+ progenitor cells , Lonza , 2C-101A.



    Similar Products

    86
    Jackson Laboratory human cord blood derived cd34 hematopoietic stem cells
    Tregs are depleted by the CCR4-CAR in a humanized mouse model. (A) Experimental design. NSG-SGM3-IL15 engrafted with <t>CD34</t> + hematopoietic stem cells were injected with 1 million CAR + CCR4-CARTs IV. Blood was collected on days 0, 3, 5, and 8, and mice were euthanized on day 11. (B) Representative flow plots showing the proportion of human CD45 (hCD45) and mCD45 leukocytes at baseline. (C) Proportion of Tregs, CD4 + non-Treg, and CD4 − cells of hCD45 percent at baseline. (D) Percentage of Tregs, non-Treg, and CD4 − cells that are CCR4 + at baseline. (E) Representative flow plots showing the CCR4 + and FOXP3 + expression on the CD4 + population before and after CART administration gated on CD4 + cells. (F-K) Proportions of Tregs, CD4 + non-Tregs, and CD4 − cells over time. Significance was determined using t tests corrected for multiple comparisons, with comparison to baseline indicated on graph; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001; ∗∗∗∗ P < .0001. M1, Mouse 1; M2, Mouse 2; M3, Mouse 3; mCD45, mouse CD45.
    Human Cord Blood Derived Cd34 Hematopoietic Stem Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/cd34+cells+hematopoietic+human+stem/pmc12955670-57-4-35
    Average 86 stars, based on 1 article reviews
    human cord blood derived cd34 hematopoietic stem cells - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc cd34+ human cord blood stem cells
    In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood <t>stem</t> <t>cells.</t> Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.
    Cd34+ Human Cord Blood Stem Cells, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/easysep+human+t+cell+isolation+kit/pmc12272481-113-0-6
    Average 90 stars, based on 1 article reviews
    cd34+ human cord blood stem cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Hemacare Inc human cord blood cd34 stem/progenitor cells
    In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood <t>stem</t> <t>cells.</t> Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.
    Human Cord Blood Cd34 Stem/Progenitor Cells, supplied by Hemacare Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/cd34++cells/10__1172_slash_jci181875-205-4-16
    Average 90 stars, based on 1 article reviews
    human cord blood cd34 stem/progenitor cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza cd34 + human cord blood stem cells
    In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood <t>stem</t> <t>cells.</t> Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.
    Cd34 + Human Cord Blood Stem Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/4d+nucleofector/pm40645177-875-9-21
    Average 90 stars, based on 1 article reviews
    cd34 + human cord blood stem cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Charles River Laboratories human cord blood cd34 + hematopoietic stem and progenitor cells (hspcs)
    In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood <t>stem</t> <t>cells.</t> Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.
    Human Cord Blood Cd34 + Hematopoietic Stem And Progenitor Cells (Hspcs), supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/cd34++cells/pmc12090235-56-0-12
    Average 90 stars, based on 1 article reviews
    human cord blood cd34 + hematopoietic stem and progenitor cells (hspcs) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza human cord blood cd34+ hematopoietic stem cells (hscs)
    In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood <t>stem</t> <t>cells.</t> Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.
    Human Cord Blood Cd34+ Hematopoietic Stem Cells (Hscs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/4d+nucleofector/pm40209717-543-10-19
    Average 90 stars, based on 1 article reviews
    human cord blood cd34+ hematopoietic stem cells (hscs) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Lonza human cord blood cd34+ stem/progenitor cells
    Representative images of different types of <t>CD34</t> + derived colonies
    Human Cord Blood Cd34+ Stem/Progenitor Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/4d+nucleofector/pmc11999203-27-0-7
    Average 90 stars, based on 1 article reviews
    human cord blood cd34+ stem/progenitor cells - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Janvier Labs nxg-mice engrafted with cord blood-derived human cd34+stem cells (nxg-his)
    Representative images of different types of <t>CD34</t> + derived colonies
    Nxg Mice Engrafted With Cord Blood Derived Human Cd34+Stem Cells (Nxg His), supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/nxg++mice+engrafted+with+cord+bloodderived+human+cd34+stem+cells++nxg++his+/pmc12258353-249-9-21
    Average 90 stars, based on 1 article reviews
    nxg-mice engrafted with cord blood-derived human cd34+stem cells (nxg-his) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    STEMCELL Technologies Inc cd34+ human stem cells from cord blood stemcell cat. 70008
    Representative images of different types of <t>CD34</t> + derived colonies
    Cd34+ Human Stem Cells From Cord Blood Stemcell Cat. 70008, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd34+++human+cord+blood+stem+cells/easysep+human+t+cell+isolation+kit/us12157768-1126-23-25
    Average 90 stars, based on 1 article reviews
    cd34+ human stem cells from cord blood stemcell cat. 70008 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Tregs are depleted by the CCR4-CAR in a humanized mouse model. (A) Experimental design. NSG-SGM3-IL15 engrafted with CD34 + hematopoietic stem cells were injected with 1 million CAR + CCR4-CARTs IV. Blood was collected on days 0, 3, 5, and 8, and mice were euthanized on day 11. (B) Representative flow plots showing the proportion of human CD45 (hCD45) and mCD45 leukocytes at baseline. (C) Proportion of Tregs, CD4 + non-Treg, and CD4 − cells of hCD45 percent at baseline. (D) Percentage of Tregs, non-Treg, and CD4 − cells that are CCR4 + at baseline. (E) Representative flow plots showing the CCR4 + and FOXP3 + expression on the CD4 + population before and after CART administration gated on CD4 + cells. (F-K) Proportions of Tregs, CD4 + non-Tregs, and CD4 − cells over time. Significance was determined using t tests corrected for multiple comparisons, with comparison to baseline indicated on graph; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001; ∗∗∗∗ P < .0001. M1, Mouse 1; M2, Mouse 2; M3, Mouse 3; mCD45, mouse CD45.

    Journal: Blood Advances

    Article Title: CAR T cells targeting CCR4 selectively deplete human Tregs ex vivo and in vivo

    doi: 10.1182/bloodadvances.2025017573

    Figure Lengend Snippet: Tregs are depleted by the CCR4-CAR in a humanized mouse model. (A) Experimental design. NSG-SGM3-IL15 engrafted with CD34 + hematopoietic stem cells were injected with 1 million CAR + CCR4-CARTs IV. Blood was collected on days 0, 3, 5, and 8, and mice were euthanized on day 11. (B) Representative flow plots showing the proportion of human CD45 (hCD45) and mCD45 leukocytes at baseline. (C) Proportion of Tregs, CD4 + non-Treg, and CD4 − cells of hCD45 percent at baseline. (D) Percentage of Tregs, non-Treg, and CD4 − cells that are CCR4 + at baseline. (E) Representative flow plots showing the CCR4 + and FOXP3 + expression on the CD4 + population before and after CART administration gated on CD4 + cells. (F-K) Proportions of Tregs, CD4 + non-Tregs, and CD4 − cells over time. Significance was determined using t tests corrected for multiple comparisons, with comparison to baseline indicated on graph; ∗ P < .05; ∗∗ P < .01; ∗∗∗ P < .001; ∗∗∗∗ P < .0001. M1, Mouse 1; M2, Mouse 2; M3, Mouse 3; mCD45, mouse CD45.

    Article Snippet: Mice were engrafted with human cord blood–derived CD34 + hematopoietic stem cells, and females were available for use at age 13 to 18 weeks after evaluation of engrafted human cell populations by flow cytometry at The Jackson Laboratory.

    Techniques: Injection, Expressing, Comparison

    In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood stem cells. Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.

    Journal: eBioMedicine

    Article Title: Effectorless Fc-fusion improves FLT3L drug-like properties for cancer immunotherapy combinations

    doi: 10.1016/j.ebiom.2025.105822

    Figure Lengend Snippet: In vitro characterisation of FLT3L-Fc NG2LH activity . Representative sensorgrams of FLT3L-Fc NG2LH binding to recombinant human monomeric FLT3-monoFc (a) and dimeric FLT3-Fc (b). Black solid lines are curves fit to the data using a 1:1 binding model, and coloured lines are raw data. The tested recombinant human FLT3-monoFc concentrations (from bottom to top) are 62.5, 125, 250, 500, 1000, and 2000 nM; recombinant human dimeric FLT3-Fc concentrations (from bottom to top) are 3.75, 7.5, 15, 30, 60, and 120 nM. The sensorgrams were generated after in-line reference cell correction followed by buffer sample subtraction. The experiments were conducted at 37 °C. (c) Binding affinities of recombinant human monomeric FLT3-monoFc and dimeric FLT3-Fc proteins to captured FLT3L-Fc NG2LH. k a association rate constant; k d dissociation rate constant; K D equilibrium dissociation constant. Data for FLT3L-Fc NG2LH binding to recombinant human FLT3-monoFc were averaged from three independent experimental Biacore runs. Data for FLT3L-Fc NG2LH binding to recombinant human dimeric FLT3-Fc were averaged from two independent experimental Biacore runs. (d) ADCP for FLT3L-Fc NG2LH and its variants. Data shown are a representative set taken from one of three independent experiments. Average (SD) of duplicate values are shown. (e) Proliferation of OCI-AML5 cells in vitro. A representative dose response curve is shown, Average (SD) of triplicate values. Data were normalised to 10 μg/mL FLT3L-Fc NG2LH as the maximum (100%) response and the assay media alone control as the minimum (0%) response. (f) Human cDC1 differentiation from cord blood stem cells. Frequency of cDC1 at the end of culture is shown (percent of live cells). Results were obtained from 2 donors. (g) In vitro proliferation of mouse bone marrow cells in response to mFLT3L or mFLT3L-Fc. Average (SD) of duplicate values are shown.

    Article Snippet: CD34+ human cord blood stem cells (StemCell Technologies) were seeded at 5000 cells per well in 96-well U-bottom plates (Costar) in 100 μL expansion media (StemSpan media–StemCell Technologies, 10% FBS, 40 ng/mL IL-3, 200 ng/mL SCF, 100 ng/mL TPO–cytokines from Peprotech).

    Techniques: In Vitro, Activity Assay, Binding Assay, Recombinant, Generated, Control

    Representative images of different types of CD34 + derived colonies

    Journal: STAR Protocols

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells

    doi: 10.1016/j.xpro.2025.103722

    Figure Lengend Snippet: Representative images of different types of CD34 + derived colonies

    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Techniques: Derivative Assay

    Gating strategy for flow cytometry analysis Representative gating strategy relative to cell viability, GFP expression, and lineage composition analyses in Blood and SP (A) or BM (B). (A) Human CD45+ cells were detected gating on live cells (7AAD-). Within this gate, GFP+ cells and My, B, and T cells were distinguished: My cells were identified as CD45+/CD13+; B cells as CD45+/CD19+; T cells as CD45+/CD19-/CD13-/CD3+ and CD19-/CD13-/CD3+/CD8+. CD19-/CD13-/CD3-/CD8- cells were defined as “Other”. (B) Human CD45+ cells were detected gating on live cells (7AAD-). Within this gate, GFP+ cells and My, B, T cells, and HSPCs were distinguished: My cells were identified as CD45+/CD13+; B cells as CD45+/CD19+; T cells as CD45+/CD19-/CD13-/CD3+; and HSPCs as CD45+/CD19-/CD13-/CD3-/CD34+. CD45+/CD19-/CD13-/CD3-/CD34- cells were defined as “Other”.

    Journal: STAR Protocols

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells

    doi: 10.1016/j.xpro.2025.103722

    Figure Lengend Snippet: Gating strategy for flow cytometry analysis Representative gating strategy relative to cell viability, GFP expression, and lineage composition analyses in Blood and SP (A) or BM (B). (A) Human CD45+ cells were detected gating on live cells (7AAD-). Within this gate, GFP+ cells and My, B, and T cells were distinguished: My cells were identified as CD45+/CD13+; B cells as CD45+/CD19+; T cells as CD45+/CD19-/CD13-/CD3+ and CD19-/CD13-/CD3+/CD8+. CD19-/CD13-/CD3-/CD8- cells were defined as “Other”. (B) Human CD45+ cells were detected gating on live cells (7AAD-). Within this gate, GFP+ cells and My, B, T cells, and HSPCs were distinguished: My cells were identified as CD45+/CD13+; B cells as CD45+/CD19+; T cells as CD45+/CD19-/CD13-/CD3+; and HSPCs as CD45+/CD19-/CD13-/CD3-/CD34+. CD45+/CD19-/CD13-/CD3-/CD34- cells were defined as “Other”.

    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Techniques: Flow Cytometry, Expressing

    Representative gating strategy relative to cell viability, subpopulation composition, and GFP expression analyses of GE-HSPCs Alive cells: 7AAD − /Annexin V − ; early apoptotic cells: 7AAD − /Annexin V + ; late apoptotic cells: 7AAD + /Annexin V + ; necrotic cells: 7AAD + /Annexin V − . CD34 + cells were identified within alive cells, and within this gate, GFP + cells and HSPC subpopulations were distinguished as CD34 + CD133 − CD90 − , CD34 + CD133 + CD90 − , or CD34 + CD133 + CD90 + . The percentage of GFP + cells was then detected within each population.

    Journal: STAR Protocols

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells

    doi: 10.1016/j.xpro.2025.103722

    Figure Lengend Snippet: Representative gating strategy relative to cell viability, subpopulation composition, and GFP expression analyses of GE-HSPCs Alive cells: 7AAD − /Annexin V − ; early apoptotic cells: 7AAD − /Annexin V + ; late apoptotic cells: 7AAD + /Annexin V + ; necrotic cells: 7AAD + /Annexin V − . CD34 + cells were identified within alive cells, and within this gate, GFP + cells and HSPC subpopulations were distinguished as CD34 + CD133 − CD90 − , CD34 + CD133 + CD90 − , or CD34 + CD133 + CD90 + . The percentage of GFP + cells was then detected within each population.

    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Techniques: Expressing

    Journal: STAR Protocols

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells

    doi: 10.1016/j.xpro.2025.103722

    Figure Lengend Snippet:

    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Techniques: Blocking Assay, Recombinant, CRISPR, Staining, Lysis, Western Blot, Saline, Bicinchoninic Acid Protein Assay, Software, Single Cell Gel Electrophoresis, Cell Culture, Bioassay, Membrane

    BM human chimerism and lineage composition

    Journal: STAR Protocols

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells

    doi: 10.1016/j.xpro.2025.103722

    Figure Lengend Snippet: BM human chimerism and lineage composition

    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Techniques:

    Cellular and Molecular assays

    Journal: STAR Protocols

    Article Title: Protocol for optimizing culture conditions for ex vivo activation during CRISPR-Cas9 gene editing in human hematopoietic stem and progenitor cells

    doi: 10.1016/j.xpro.2025.103722

    Figure Lengend Snippet: Cellular and Molecular assays

    Article Snippet: Human cord blood CD34+ stem/progenitor cells , Lonza , Cat#2C-101.

    Techniques: